Related Experiment Videos
Serum immunoreactive trypsin in cystic fibrosis
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1980
Summary
Immuno-reactive trypsin (IR-TRY) levels were measured in 185 cystic fibrosis (CF) patients. IR-TRY correlated with age and pancreatic function, supporting its use in neonatal screening for CF.
Area of Science:
- Biochemistry
- Pediatrics
- Genetics
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
- Early diagnosis of CF is crucial for timely intervention and improved outcomes.
- Immuno-reactive trypsin (IR-TRY) is a potential biomarker for CF.
Purpose of the Study:
- To measure immuno-reactive trypsin (IR-TRY) levels in a cohort of cystic fibrosis (CF) patients.
- To investigate the correlation between IR-TRY levels, patient age, and pancreatic functional status.
- To evaluate the utility of IR-TRY measurements for neonatal screening of CF.
Main Methods:
- Radioimmunoassay (RIA) was employed to quantify IR-TRY levels.
- The study included 185 patients diagnosed with CF, ranging in age from 4 days to 34 years.
- Statistical analysis was performed to assess correlations.
Main Results:
- IR-TRY levels were successfully measured in all 185 CF patients.
- Significant correlations were observed between IR-TRY values and patient age.
- IR-TRY levels also showed a correlation with the functional state of the pancreas.
Conclusions:
- IR-TRY measurement is a feasible method for assessing trypsin levels in CF patients.
- The observed correlations suggest IR-TRY can provide insights into pancreatic function in CF.
- These findings support the potential application of IR-TRY in neonatal screening protocols for cystic fibrosis.